Effectiveness of the BNT162b2 mRNA COVID-19 vaccine among adolescents with juvenile-onset inflammatory rheumatic diseases (IRDs).

Dr Amit Ziv and Prof Yosef Uziel (both Tel Aviv University and Meir Medical Center, Israel) join Dr Herman Tam to discuss the effectiveness of the BNT162b2 mRNA COVID-19 vaccine in preventing infection in adolescents with juvenile-onset IRDs.

You can read this article in Rheumatology.

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.